TrialThe AAPS journal2020

Model-Based Characterization of the Pharmacokinetics, Target Engagement Biomarkers, and Immunomodulatory Activity of PF-06342674, a Humanized mAb Against IL-7 Receptor-α, in Adults with Type 1 Diabetes.

Jason H Williams et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.